Chronotherapy leveraging dietary context overcomes circadian rhythm influence on cancer cell response to PPAR antagonists
Bruno et al. demonstrate that feeding-fasting cycles, rather than tumor-intrinsic clocks, govern colorectal cancer sensitivity to PPAR antagonists. These findings highlight how dietary timing can maximize anticancer efficacy of metabolic drugs while minimizing toxicity for healthy tissues.